Who are the Institutional Holders in Arbutus Biopharma Corp (ABUS)?
Arbutus Biopharma Corp (NASDAQ: ABUS) is 51.60% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Here are the top Institutional holders of Arbutus Biopharma Corp (ABUS) shares
Arbutus Biopharma Corp (NASDAQ: ABUS) is 56.00% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Things appear to be looking up for Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (NASDAQ: ABUS) is 60.80% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Arbutus Biopharma Corp (ABUS) – Don’t Be So Quick to Call it Dead
Arbutus Biopharma Corp (NASDAQ: ABUS) is 65.20% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Check out this: Arbutus Biopharma Corp (ABUS) could be on the verge of a big rally
Arbutus Biopharma Corp (NASDAQ: ABUS) is 82.00% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.52 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
ABUS Stock Forecast: All the More Reason to Consider Arbutus Biopharma Corp (ABUS) Now
Arbutus Biopharma Corp (NASDAQ: ABUS) is 59.60% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $3.98 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
